doi: 10.1038/sj.ijo.0801083 Summary Keywords Prader-Willi syndrome, obesity, GLP-1 receptor agonist, semaglutide, metabolic surgery Citation Koceva A, Mleku Kozamernik K, Jane A, Herman R, Ferjan S and Jensterle M (2025) Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review
The most common adverse effects are gastrointestinal in nature, including diarrhea, constipation, abdominal cramping, and flatulence
A report from PricewaterhouseCoopers found that GLP-1 drugs drove a disproportionate share of the $50 billion hike in pharmacy spending in 2024 (up from a $20 billion increase in 2023)
At Snap Glam, we enhance your results by pairing Semaglutide with Vitamin B12, which boosts energy, supports metabolism, improves mood, and reduces fatigue during weight loss
Here are some of the key insights that caught my attention